DHR-Sponsored Training Programme at ICMR-CRMCH Week 2 – Day 4 – ICMR-NIRBID
ICMR-NIRBID shared a post on LinkedIn:
“Week 2 – Day 4 Highlights | DHR-Sponsored Training Programme at ICMR-CRMCH, Chandrapur
The ongoing DHR-sponsored 4-week training programme at ICMR-CRMCH, Chandrapur, continued with expert sessions covering therapeutic advances, patient management, and translational research in haemoglobinopathies.
- Dr. Nita Radhakrishnan, Additional Professor and Head, PGICH, Noida, delivered an insightful online session on Hydroxyurea Therapy for Sickle Cell Disease, discussing current evidence, treatment protocols, and its impact on improving clinical outcomes.
- Dr. Atish Bakane, Haematologist, Nagpur, conducted comprehensive sessions on Advanced Treatment Strategies for Haemoglobinopathies, including Hematopoietic Stem Cell Transplantation (HSCT)/Bone Marrow Transplantation (BMT), along with evidence-based approaches to Pain Management in Sickle Cell Disease.
- Dr. Rikesh K. Dubey, SRM University, presented an engaging lecture on Studying Sickle Cell Disease Using Animal Models, highlighting the role of experimental models in advancing our understanding of disease pathophysiology and therapeutic development.
Together, these sessions offered participants valuable insights into the continuum of haemoglobinopathy research—from laboratory models and translational science to advanced clinical management and curative therapies.”
Nita Radhakrishnan, Additional Professor and HOD of Pediatric Hematology-Oncology at Post Graduate Institute of Child Health, shared ICMR-NIRBID’s post on LinkedIn:
“Precision medicine is redefining hemoglobinopathy care—from optimized hydroxy urea in sickle cell disease to curative HSCT and future targeted therapies.
Happy to contribute”
Stay updated with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia